Spruce Biosciences, Inc. Common Stock (SPRB)

• Market cap: $118M
• 1 day: 5.19%
• 5 days: -0.9%
• 1 month: -10.58%
• 3 months: 1,022.45%
• 6 months: 1,022.45%
• Year to date: 249.65%
• 1 year: 176.8%
• 5 years: -95.48%
• 10 years: -91.37%
• Sector: Healthcare
• Industry: Biotechnology

About: Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT), and Tildacerfont/ Cortibon, a Companion Diagnostic, developed in partnership with HMNC Brain Health.

Employees: 20